Management of shock in acute myocardial infarction.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002302:Cardiac Output; D002496:Central Venous Pressure; D003911:Dextrans / Q000008:administration & dosage / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006439:Hemodynamics; D006801:Humans; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000627:therapeutic use; D008616:Mephentermine / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D003911:Dextrans; D004071:Digitalis Glycosides; D014665:Vasodilator Agents; D005934:Glucagon; D005947:Glucose; D007545:Isoproterenol; D008616:Mephentermine; D004298:Dopamine; D009638:Norepinephrine